LGALS9 and COVID-19: Plasma levels of Gal-9 were significantly higher in COVID-19 patients compared to healthy controls. In addition, Gal-9 levels were higher in severe COVID-19 patients compared to mild-to-moderate ones. A cut-off of 2042 pg/mL separated controls from COVID-19 patients with 95% sensitivity and 95% specificity.